Integrated learning system
Clinical development as a sequence of uncertainty-reducing decisions, not a list of studies.
Indication, TPP and development thesis
Connect unmet need, biology, population, differentiation and value into a testable thesis.
Program, protocol, endpoint and estimand architecture
Design evidence that remains clinically meaningful and statistically interpretable.
Regulatory science, ethics, safety and quality
Integrate approval strategy, participant protection, risk and evidence integrity.
HTA, HEOR, Medical Affairs and commercial evidence
Build payer, adoption and lifecycle questions into the evidence architecture.
Applied capstone
Complete a trial autopsy or integrated development plan and defend the decisions.